“Pennsylvania is a leader in life science innovation, and major investments like this from Eurofins are supporting the continued growth of this critically important industry,” said Pennsylvania Governor Shapiro.
Eurofins BioPharma Product Testing (BPT) in Lancaster, PA, has begun construction on the largest expansion project in the campus’ history. Celebrating its 65th anniversary this year, the company broke ground in May 2026 on the $147.5 million, two-building O & P expansion project, which comprises 300,000 ft2 of laboratory and office structures. When complete, the campus will be among the largest sites in the Eurofins network of laboratories, which includes more than 950 locations in 57 countries and one of the largest biopharmaceutical testing laboratories in the world.
Building O is a six-storey, 135,000 ft2 consolidated office building. Building P is a five-storey, 165,000 ft2 laboratory facility. The project will create 250 new jobs over the next three years and retain 3,080 existing positions, further strengthening Eurofins BPT’s ability to deliver timely scientific solutions to the growing challenges faced by its clients in the biopharmaceutical and medical device industries.
“We have the strategic location, robust research infrastructure, and skilled workforce that help biotech companies deliver timely therapies to patients and make the world healthier and safer,” said Pennsylvania’s Governor Shapiro. “My Administration will continue to make strategic investments that further strengthen this important industry, create jobs, and drive even more economic growth across our Commonwealth.”
“As one of Lancaster County’s largest employers, we are proud to expand our capacity and services for our global clients while offering outstanding career opportunities. This growth reflects the dedication and expertise of our team in building strong partnerships with the clients we serve,” said Neal Salerno, Senior Vice President, Eurofins BioPharma Product Testing, NA. “We are grateful for Eurofins Scientific’s commitment to funding growth that strengthens customer service and further expands the world’s most comprehensive testing network. Our long-term investments in this space set us apart and open exciting opportunities for the future.”
Bringing the 49-acre campus’ building footprint to more than 1 million ft2 buildings O and Building P are scheduled for completion by the end of 2028.